On Friday, the Food and Drug Administration (FDA) revealed its approval of Pfizer’s treatment for a rare genetic bleeding disorder, marking the company’s debut gene therapy to receive clearance in the U.S. Marketed under the name Beqvez, the drug has been given the green light by the agency for adults ...
Read More »Pfizer Ceases Production of Dual-Dose Weight Loss Medication Following Elevated Incidence of Adverse Effects
On Friday, Pfizer announced the discontinuation of the development of the twice-daily variant of its experimental weight loss pill. This decision follows a mid-stage clinical study where obese patients experienced substantial weight loss while facing challenges in tolerating the drug. The pharmaceutical company noted elevated rates of adverse side effects, ...
Read More »